Figure S3 from Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4⁺Foxp3⁻ Cell–Mediated Modulation of CD103⁺ Dendritic Cells

Abstract

<p>Supplementary Figure 3</p>